BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 15368312)

  • 21. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The histological outcome of glandular dyskaryosis--AGUS--reported in Papanicolaou smears.
    Iavazzo C; Vorgias G; Alexiadou A; Lekka I; Mavromatis I; Akrivos T; Katsoulis M
    J BUON; 2008; 13(1):97-100. PubMed ID: 18404794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis.
    Pacey F; Ayer B; Greenberg M
    Acta Cytol; 1988; 32(3):325-30. PubMed ID: 3376699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of cervical neoplasia.
    La Vecchia C
    Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening.
    Plaxe SC; Saltzstein SL
    Gynecol Oncol; 1999 Oct; 75(1):55-61. PubMed ID: 10502426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenocarcinoma in situ of the cervix.
    Schoolland M; Segal A; Allpress S; Miranda A; Frost FA; Sterrett GF
    Cancer; 2002 Dec; 96(6):330-7. PubMed ID: 12478680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and histological significance of atypical glandular cell on Pap smear.
    Behtash N; Nazari Z; Fakhrejahani F; Khafaf A; Azar EG
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):46-9. PubMed ID: 17261100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
    Bai H; Sung CJ; Steinhoff MM
    Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological screening for cervical cancer in the province of Limburg, Belgium.
    Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
    Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The minimally abnormal Papanicolaou smear.
    Brotzman GL; Julian TM
    Am Fam Physician; 1996 Mar; 53(4):1154-62. PubMed ID: 8629563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.
    Lee KR; Manna EA; Jones MA
    Acta Cytol; 1991; 35(1):117-26. PubMed ID: 1994620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after a cytological prediction of glandular abnormality.
    Mitchell HS
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):436-40. PubMed ID: 15387866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papanicolaou tests with coexisting squamous and glandular abnormalities.
    Khor LY; Abdul-Karim FW; Bruening AE; Weber Noffsinger DK; Booth CN
    Cancer Cytopathol; 2014 Aug; 122(8):620-6. PubMed ID: 24938897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytologic features of squamous cell carcinoma in situ involving endocervical glands in endocervical cytobrush specimens.
    Selvaggi SM
    Acta Cytol; 1994; 38(5):687-92. PubMed ID: 8091898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. I. Adenocarcinoma in situ.
    Ayer B; Pacey F; Greenberg M; Bousfield L
    Acta Cytol; 1987; 31(4):397-411. PubMed ID: 3604534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
    Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
    Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.
    Krane JF; Granter SR; Trask CE; Hogan CL; Lee KR
    Cancer; 2001 Feb; 93(1):8-15. PubMed ID: 11241260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.